Cardiac amyloidosis (CA) is an underdiagnosed condition caused by the deposition of
misfolded proteins, namely immunoglobulin light chains and transthyretin, in the …

Objective Cardiac amyloidosis (CA) is an increasingly recognised condition in patients with
aortic stenosis (AS). However, there is a large variation in the reported prevalence figures …

BACKGROUND: Aortic valve calcification (AVC) indexation to the aortic annulus (AA) area
measured by Doppler echocardiography (AVCdEcho) provides powerful prognostic …

Background The frequent association between transthyretin wild‐type (TTRwt) cardiac
amyloidosis (CA) and aortic stenosis (AS) suggests a bidirectional relationship: TTRwt‐CA …

Cardiac amyloidosis represents a spectrum of conditions characterized by the accumulation
of insoluble fibrils, resulting in progressive deposition and myocardial dysfunction. The exact …

The comprehension and evaluation of aortic stenosis (AS) has advanced significantly in the
last decades. At the same time, new intervention methods has evolved greatly but there are …

Background Cardiac amyloidosis (CA) is frequently found in older patients with aortic
stenosis (AS). However, the prevalence of AS among patients with CA is unknown. The …

Aims Low-gradient (LG) aortic stenosis (AS) poses a diagnostic challenge. Aortic valve
calcium score (AVCS) assessment has emerged as a complementary diagnostic method …

Background Some patients have severe aortic valve stenosis (AS) despite a lower degree of
aortic valve calcification (AVC). This study compared the clinical features and prognosis of …

Cardiac amyloidosis (CA) requires a tailored treatment that is no less important than
therapies targeting the amyloidogenic cascade. The main challenges are the management …